Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
dimethyl fumarate polpharma
zaklady farmafarmaceutyczne polpharma s.aceutyczne polpharma s.a. - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate polpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
dimethyl fumarate teva
teva gmbh - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - dimethyl fumarate teva is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
dimethyl fumarate accord
accord healthcare s.l.u. - dimethyl fumarate - multiple sclerosis, relapsing-remitting; multiple sclerosis - imūnsupresanti - dimethyl fumarate accord is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
dimethyl fumarate mylan
mylan ireland limited - dimethyl fumarate - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - dimethyl fumarate mylan is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
tecfidera
biogen netherlands b.v. - dimethyl fumarate - multiplā skleroze - imūnsupresanti - tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (rrms).
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
skilarence
almirall s.a - dimethyl fumarate - psoriāze - imūnsupresanti - slimība ir indicēta vidēji smagas vai smagas plaknes psoriāzes ārstēšanai pieaugušajiem, kuriem nepieciešama sistēmiska zāļu terapija.
Ευρωπαϊκή Ένωση -
Λετονικά -
EMA (European Medicines Agency)
vumerity
biogen netherlands b.v. - diroximel fumarate (biib098) - multiplā skleroze, recidivējoši-pārskaitot - imūnsupresanti - vumerity is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (see section 5. 1 for important information on the populations for which efficacy has been established).
Λετονία -
Λετονικά -
Zāļu valsts aģentūra
fingolimod norameda 0,5 mg cietās kapsulas
norameda uab, lithuania - fingolimods - kapsula, cietā - 0,5 mg
Λετονία -
Λετονικά -
Zāļu valsts aģentūra
fingolimod zentiva 0,5 mg cietās kapsulas
zentiva, k.s., czech republic - fingolimods - kapsula, cietā - 0,5 mg
Λετονία -
Λετονικά -
Zāļu valsts aģentūra
fingolimod medochemie 0,5 mg cietās kapsulas
medochemie ltd., cyprus - fingolimods - kapsula, cietā - 0,5 mg